These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29279706)

  • 1. Metachronous and Synchronous Occurrence of 5 Primary Malignancies in a Female Patient between 1997 and 2013: A Case Report with Germline and Somatic Genetic Analysis.
    Nyqvist J; Persson F; Parris TZ; Helou K; Kenne Sarenmalm E; Einbeigi Z; Borg Å; Karlsson P; Kovács A
    Case Rep Oncol; 2017; 10(3):1006-1012. PubMed ID: 29279706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast and Ovarian Cancer Penetrance Estimates Derived From Germline Multiple-Gene Sequencing Results in Women.
    Kurian AW; Hughes E; Handorf EA; Gutin A; Allen B; Hartman AR; Hall MJ
    JCO Precis Oncol; 2017 Nov; 1():1-12. PubMed ID: 35172496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characteristics of young-onset colorectal cancer in Vietnamese patients.
    Do MD; Nguyen TH; Le KT; Le LHG; Nguyen BH; Le KT; Doan TPT; Ho CQ; Nguyen HN; Tran TD; Vu HA
    Asia Pac J Clin Oncol; 2022 Dec; 18(6):678-685. PubMed ID: 35098669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterozygous Pathogenic Nonsense Variant in the
    Guadagnolo D; Mastromoro G; Marchionni E; Germani A; Libi F; Sadeghi S; Savio C; Petrucci S; De Marchis L; Piane M; Pizzuti A
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
    Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
    Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA2, PALB2, RECQL4 Germline Pathogenic Variants, and Somatic TP53 Mutation in Triple Metachronous Malignancies: A Case Report and Literature Review.
    Liu Y; Yang H; Fu X; Zhong L; Xu P; Fang F; Liu Y; Li Q; Yan Y; Wei S; Wang J; Zhang C
    Int Med Case Rep J; 2024; 17():23-29. PubMed ID: 38223534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
    Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
    Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing based detection of germline and somatic alterations in a patient with four metachronous primary tumors.
    Martin M; Sabari JK; Turashvili G; Halpenny DF; Rizvi H; Shapnik N; Makker V
    Gynecol Oncol Rep; 2018 May; 24():94-98. PubMed ID: 29915805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
    Moretta J; Berthet P; Bonadona V; Caron O; Cohen-Haguenauer O; Colas C; Corsini C; Cusin V; De Pauw A; Delnatte C; Dussart S; Jamain C; Longy M; Luporsi E; Maugard C; Nguyen TD; Pujol P; Vaur D; Andrieu N; Lasset C; Noguès C;
    Bull Cancer; 2018 Oct; 105(10):907-917. PubMed ID: 30268633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer.
    Weitzel JN; Neuhausen SL; Adamson A; Tao S; Ricker C; Maoz A; Rosenblatt M; Nehoray B; Sand S; Steele L; Unzeitig G; Feldman N; Blanco AM; Hu D; Huntsman S; Castillo D; Haiman C; Slavin T; Ziv E
    Cancer; 2019 Aug; 125(16):2829-2836. PubMed ID: 31206626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer.
    Holowatyj AN; Washington MK; Tavtigian SV; Eng C; Horton C
    JAMA Oncol; 2022 Nov; 9(1):95-101. PubMed ID: 36368039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple synchronous primary malignancies of the colon, endometrium and kidney in a patient with Lynch syndrome treated via minimally invasive techniques.
    Mendez LE; Atlass J
    Gynecol Oncol Rep; 2016 Aug; 17():29-32. PubMed ID: 27331139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes.
    Peleg Hasson S; Menes T; Sonnenblick A
    Pharmgenomics Pers Med; 2020; 13():227-238. PubMed ID: 32801835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple primary malignancies in BRCA1 mutation carriers--two clinical cases].
    Badora A; Kaleta B; Nowara E; Sikora-Jopek M; Budryk M; Smok-Ragankiewicz A
    Ginekol Pol; 2013 Oct; 84(10):892-6. PubMed ID: 24273914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
    Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
    Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary genes and SNPs associated with breast cancer.
    Mahdi KM; Nassiri MR; Nasiri K
    Asian Pac J Cancer Prev; 2013; 14(6):3403-9. PubMed ID: 23886119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited Mutations in Women With Ovarian Carcinoma.
    Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ
    JAMA Oncol; 2016 Apr; 2(4):482-90. PubMed ID: 26720728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for hereditary nonpolyposis colorectal cancer-associated synchronous and metachronous malignancies in patients with microsatellite instability-positive endometrial carcinoma lacking MLH1 promoter methylation.
    Buttin BM; Powell MA; Mutch DG; Rader JS; Herzog TJ; Gibb RK; Huettner P; Edmonston TB; Goodfellow PJ
    Clin Cancer Res; 2004 Jan; 10(2):481-90. PubMed ID: 14760069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.